340B hospitals need new transparency requirements and program eligibility rules to ensure the sustainability of the program, Republican lawmakers said [...] …
Year: 2024
A key House subcommittee oversight hearing today on the 340B program will include a witness who previously said Congress should [...] …
Vertex Pharmaceuticals has become the 33rd drugmaker to place 340B contract pharmacy restrictions, but the new policy exempts all six [...] …
SPONSORED CONTENT
All entities who participate in the 340B program are subject to an Office of Pharmacy Affairs (OPA) audit regardless of entity type, size or volume of transactions. For the last five years, HRSA’s OPA has been completing approximately 200 audits a year and
…
An influential drug industry group and a major drugmaker each filed lawsuits challenging West Virginia’s 340B contract pharmacy access law [...] …
Drugmaker UCB recently told 340B providers in Arkansas that it will exempt them from its contract pharmacy restrictions. In a [...] …
Generic and biosimilar drugmaker Sandoz recently added a drug used in conjunction with cancer treatments to its list of drugs [...] …
The federal office tasked with overseeing the 340B program will brief covered entities and manufacturers next week on the administrative [...] …
In last month’s column, I wrote about a reprehensible campaign by 340B opponents to tie this vital drug discount program [...] …
Mississippi this week became the fourth state to face a legal challenge to its 340B contract pharmacy law, when the [...] …